Charlene Caburnay from the Health Communications Research Lab presented to the Health Data Initiative Forum today about Ozioma, winner of the Health 2.0 and National Cancer Institute Developer Challenge.
Today the Department of Health and Human Services and the Institute of Medicine are holding their second forum to discuss how health data can be used to support healthcare systems and patients in informed decision making. More than 40 companies will be participating, and the featured speakers... Read more
What does it take to find a cure for Alzheimer’s? Can we spare returning soldiers from post-traumatic stress disorder? The moon shot is on collaboration and sharing. And just as in the moon race, the challenge is far too great for a single group to undertake it alone.
"If I tell you that this is the greatest good for a human being, to engage every day in arguments about virtue and the other things you have heard me talk about, examining both myself and others, and if I tell you the unexamined life is not worth living for a human being, you will be even less... Read more
What a difference three years makes. It seems quaint now that in the 2008 NEJM there were concerns raised about the flow of health information onto the web. Back then there was but a faint trickle of what could be entered, mostly by hand, and accessed on the web. Before HITECH and health care... Read more
Last week a friend of mine posted on Facebook, “I need a new lawnmower. Any opinions on what I should get?” She received several responses. One person suggested a goat. Another posted a picture of an attractive shirtless man with bulging muscles gleaming with sweat as he worked in the yard. But... Read more
People often share more about their health and medical experiences on Facebook than they do with their own doctors. They talk about their experiences with illness, their symptoms, the medications they're taking, the side effects, what works, what doesn't, even various treatment options. It turns... Read more
Big pharma is one of the main scapegoats for the steeply rising costs of medical care. This might make sense when you learn how staggering the pricetag on necessary processes—like clinical trials—can be. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), the U.S.... Read more
Could patent restrictions in biotech be compromising millions' health, safety, and standards of living when we should be benefiting from new diagnostic tests or improved medicines?
Many of us, at some point in our lives, have had to deal with a variety of different healthcare professionals for an episode of care. Perhaps your primary physician has referred you to a specialist, or the ER doctor required you to see your primary physician for follow-up, or you've been admitted... Read more